BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

AUDENTES THERAPEUTICS — Lobbying — Receipts Report

LD-2 disclosure · Registration

AUDENTES THERAPEUTICS

via KING & SPALDING LLP

3rd Quarter (July 1 - Sep 30) · 2018Posted Sept 14, 2018Filing document ↗LDA record ↗

Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.

Client

Name: AUDENTES THERAPEUTICS
Description: Biotechnology company
Location: California · United States of America

Registrant

Firm: KING & SPALDING LLP
Description: Law firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Addressing value-based payments for regenerative medicines
Lobbyistsmr DAVID JOSEPH FARBER

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.